# US 2026/0174811 A1 · Method of fixating and stabilizing nitric oxide metabolites through fermentation of nitrogen-containing natural substance

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0174811 A1
- Document ID: US20260174811A1
- Status: Published application
- Kind: A1
- Application number: 19/543,066
- Filed: 2026-02-18
- Published: 2026-06-25
- Earliest claimed: 2019-10-29
- Inventors: HYUN-SOO CHUN
- Web page: https://patentgrep.com/patent/US20260174811A1

## CPC

- A61K 35/747: Lactobacilli, e.g. L. acidophilus or L. brevis
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A61K 35/741: Probiotics (probiotic yeast, e.g. saccharomyces A61K36/06)
- A61K 35/742: Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
- A61K 35/744: Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K 35/745: Bifidobacteria
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 9/12: Antihypertensives
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- C12N 1/205: Bacterial isolates
- C12P 3/00: Preparation of elements or inorganic compounds except carbon dioxide {(recovery of carbon dioxides as by-products C12F3/02)}
- C12P 13/008: {containing a N-O bond, e.g. nitro (-NO2), nitroso (-NO)}
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A23V 2400/123: Bulgaricus
- A23V 2400/145: Gasseri
- A23V 2400/147: Helveticus
- A23V 2400/157: Lactis
- A23V 2400/175: Rhamnosus
- A23V 2400/517: Bifidum
- A23V 2400/529: Infantis
- A23V 2400/533: Longum
- C12R 2001/125: Bacillus subtilis {; Hay bacillus; Grass bacillus}
- Y02A 50/20: Air quality improvement or preservation, e.g. vehicle emission control or emission reduction by using catalytic converters
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

This invention relates to a method of fixating and stabilizing nitric oxide metabolites through fermentation of nitrogen-containing natural substance. According to the method of the invention, the fermentation efficiency is maximized by optimizing the fermentation conditions so that the productivity of nitric oxide metabolites is significantly improved. Thus, eating a fermented natural substance in which nitric oxide metabolites are fixated and stabilized by the method of the present invention would be helpful for maintaining the homeostasis of human body, in which nitric oxide synthase is either absent or insufficient, based on vasodilation and activation of a neurotransmitter and immune function as medical efficacy of nitric oxide.

## Claims

### Claim 1

A method for treating at least one selected from the group consisting of high blood pressure, diabetes, atopic dermatitis, wound, and a combination thereof, the method comprising:
administering a composition comprising a fermented natural substance to a subject in need thereof,
wherein the fermented natural substance has nitric oxide metabolites fixated and stabilized therein, the fermented natural substance is produced by a process comprising:
adding a fermentative strain to nitrogen-containing natural substance and carrying out fermentation by a batch fermentation process,
wherein the nitrogen-containing natural substance is at least one selected from the group consisting of lettuce, Sedum sarmentosum, spinach, blueberry, dandelion, pomegranate, cabbage, garlic, Morinda citrifolia, onion, soybean, bean sprout, mulberry leaf, Momordica charantia, Rubus coreanus, Houttuynia cortada, aronia, Humulus japonicus, Coptis chinensis, hijiki, hooker chive, mushrooms, calamus, wild spinach (Seomcho), Chinese cabbage, kelp, apple, mugwort, orange, salmon testis, abalone shell, shellfish shell, cricket, silkworm, Rehmannia glutinosa, and Shipjeondaebo-tang,
wherein the fermentation is carried out at a temperature in a range of 18 to 30° C. and a dissolved oxygen level in a range of 0.03 to 0.1 mg/L, and a chemical oxygen demand is 200 to 700 mg/L at an fermentation end point; and
the fermentative strain is a strain belonging to Bacillus sp., Bifidobacterium sp., Enterococcus sp., or Lactobacillus sp.

### Claim 2 (depends on 1)

The method of claim 1, wherein the composition is a pharmaceutical composition comprising the fermented natural substance as an effective component.

### Claim 3 (depends on 1)

The method of claim 1, wherein the composition is a functional health food composition comprising the fermented natural substance as an effective component.

### Claim 4 (depends on 1)

The method of claim 1, wherein the fermentation is carried out for 2 to 30 days.

### Claim 5 (depends on 1)

The method of claim 1, wherein the fermentation is carried out at 30° C. and a dissolved oxygen level of 0.04 mg/L, and a chemical oxygen demand is 450 to 700 mg/L at an fermentation end point.

### Claim 6 (depends on 1)

The method of claim 1, wherein the nitrogen-containing natural substance is lettuce.

### Claim 7 (depends on 1)

The method of claim 1, wherein the nitrogen-containing natural substance is bean sprout; and
the fermentation is carried out at the following conditions:
fermentation temperature of 30° C.;
dissolved oxygen level of 0.04 mg/L; and
chemical oxygen demand is 350 to 450 mg/L at an fermentation end point.

### Claim 8 (depends on 1)

The method of claim 1, wherein the fermentative strain is Bacillus subtilis deposited in the Korea Research Institute of Bioscience and Biotechnology under the Access number of KCTC 12501BP.

### Claim 9 (depends on 1)

The method of claim 1, wherein the batch fermentation process is a single batch fermentation process.

### Claim 10 (depends on 1)

The method of claim 1, wherein the nitrogen-containing natural substance comprises lettuce or bean sprout.

### Claim 11 (depends on 10)

The method of claim 10, wherein the fermentation is carried out with lettuce at the temperature of 18-30° C., the dissolved oxygen concentration of 0.03-0.1 mg/L, and the chemical oxygen demand of 450-700 mg/L at the fermentation end point.

### Claim 12 (depends on 10)

The method of claim 10, wherein the fermentation is carried out with bean sprout at the temperature of 18-30° C., the dissolved oxygen concentration of 0.03-0.1 mg/L, and the chemical oxygen demand of 350-450 mg/L at the fermentation end point.
